De Iaco P - Search Results

1

Post-operative residual disease and number of cycles of neoadjuvant chemotherapy in advanced epithelial ovarian carcinoma.

Perrone AM, Coada CA, Ravegnini G, De Leo A, Damiano G, De Crescenzo E, Tesei M, Di Costanzo S, Genovesi L, Rubino D, Zamagni C, De Iaco P. Perrone AM, et al. Among authors: de crescenzo e, de iaco p, de leo a. Int J Gynecol Cancer. 2023 Aug 7;33(8):1270-1278. doi: 10.1136/ijgc-2022-004249. Int J Gynecol Cancer. 2023. PMID: 37429642 Free PMC article.

2

Quantification of free plasma DNA before and after chemotherapy in patients with advanced epithelial ovarian cancer.

Capizzi E, Gabusi E, Grigioni AD, De Iaco P, Rosati M, Zamagni C, Fiorentino M. Capizzi E, et al. Among authors: de iaco p. Diagn Mol Pathol. 2008 Mar;17(1):34-8. doi: 10.1097/PDM.0b013e3181359e1f. Diagn Mol Pathol. 2008. PMID: 18303408 Clinical Trial.

3

Oestrogen receptor 1 mRNA is a prognostic factor in ovarian cancer patients treated with neo-adjuvant chemotherapy: determination by array and kinetic PCR in fresh tissue biopsies.

Zamagni C, Wirtz RM, De Iaco P, Rosati M, Veltrup E, Rosati F, Capizzi E, Cacciari N, Alboni C, Bernardi A, Massari F, Quercia S, D'Errico Grigioni A, Dietel M, Sehouli J, Denkert C, Martoni AA. Zamagni C, et al. Among authors: de iaco p. Endocr Relat Cancer. 2009 Dec;16(4):1241-9. doi: 10.1677/ERC-08-0342. Epub 2009 Sep 11. Endocr Relat Cancer. 2009. PMID: 19749010

4

FDG-PET/CT in advanced ovarian cancer staging: value and pitfalls in detecting lesions in different abdominal and pelvic quadrants compared with laparoscopy.

De Iaco P, Musto A, Orazi L, Zamagni C, Rosati M, Allegri V, Cacciari N, Al-Nahhas A, Rubello D, Venturoli S, Fanti S. De Iaco P, et al. Eur J Radiol. 2011 Nov;80(2):e98-103. doi: 10.1016/j.ejrad.2010.07.013. Epub 2010 Aug 4. Eur J Radiol. 2011. PMID: 20688446

5

[18F]FDG-PET/CT monitoring early identifies advanced ovarian cancer patients who will benefit from prolonged neo-adjuvant chemotherapy.

Martoni AA, Fanti S, Zamagni C, Rosati M, De Iaco P, D'Errico Grigioni A, Castellucci P, Quercia S, Musto A, Ricci Maccarini L, Lopci E, Bernardi A. Martoni AA, et al. Among authors: de iaco p. Q J Nucl Med Mol Imaging. 2011 Feb;55(1):81-90. Epub 2010 Nov 11. Q J Nucl Med Mol Imaging. 2011. PMID: 21068714

6

Local α-tocopherol for acute and short-term vaginal toxicity prevention in patients treated with radiotherapy for gynecologic tumors.

Galuppi A, Perrone AM, La Macchia M, Santini D, Medoro S, Maccarini LR, Strada I, Pozzati F, Rossi M, De Iaco P. Galuppi A, et al. Among authors: de iaco p. Int J Gynecol Cancer. 2011 Dec;21(9):1708-11. doi: 10.1097/IGC.0b013e318223659d. Int J Gynecol Cancer. 2011. PMID: 21795984 Clinical Trial.

7

Some criticism about laparoendoscopic single-site surgery (LESS) in gynecological surgery for benign and malignant diseases.

Perrone AM, Rossi M, De Iaco P. Perrone AM, et al. Among authors: de iaco p. Fertil Steril. 2011 Sep;96(3):e153; author reply e154. doi: 10.1016/j.fertnstert.2011.06.076. Epub 2011 Jul 29. Fertil Steril. 2011. PMID: 21802670 No abstract available.

8

Evaluation of extensive cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with advanced epithelial ovarian cancer.

Ansaloni L, Agnoletti V, Amadori A, Catena F, Cavaliere D, Coccolini F, De Iaco P, Di Battista M, Framarini M, Gazzotti F, Ghermandi C, Kopf B, Saponara M, Tauceri F, Vallicelli C, Verdecchia GM, Pinna AD. Ansaloni L, et al. Among authors: de iaco p. Int J Gynecol Cancer. 2012 Jun;22(5):778-85. doi: 10.1097/IGC.0b013e31824d836c. Int J Gynecol Cancer. 2012. PMID: 22572845 Clinical Trial.

9

Systematic pelvic and aortic lymphadenectomy in advanced ovarian cancer patients at the time of interval debulking surgery: a double-institution case-control study.

Fagotti A, De Iaco P, Fanfani F, Vizzielli G, Perelli F, Pozzati F, Perrone AM, Turco LC, Scambia G. Fagotti A, et al. Among authors: de iaco p. Ann Surg Oncol. 2012 Oct;19(11):3522-7. doi: 10.1245/s10434-012-2400-9. Epub 2012 May 30. Ann Surg Oncol. 2012. PMID: 22644507

10

Haptoglobin phenotype and epithelial ovarian cancer.

Mandato VD, Magnani E, Abrate M, Casali B, Nicoli D, Farnetti E, Formisano D, Pirillo D, Ciarlini G, De Iaco P, Strada I, Zamagni C, La Sala GB. Mandato VD, et al. Among authors: de iaco p. Anticancer Res. 2012 Oct;32(10):4353-8. Anticancer Res. 2012. PMID: 23060558

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

190 results

Search Page